Global Hereditary Genetic Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Hereditary Genetic Testing Market Research Report 2024
Hereditary genetic testing has grown significantly since the technology was first commercialized, but it is important to quantify that growth and describe future trends. The unmet clinical needs for better tools to predict, diagnose, treat, and monitor disease are acting as significant factors driving the growth of the sequencing industry. Whole-genome and exome sequencing remain relatively costly requiring initial equipment investment, specialized workforce requirements, and time-intensive variant interpretation.
According to MRAResearch’s new survey, global Hereditary Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hereditary Genetic Testing market research.
Key companies engaged in the Hereditary Genetic Testing industry include Agilent Technologies, Inc, Ambry Genetics, Beijing Genomics Institute (BGI), CENTOGENE AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Myriad Genetics, Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Hereditary Genetic Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hereditary Genetic Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hereditary Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Agilent Technologies, Inc
Ambry Genetics
Beijing Genomics Institute (BGI)
CENTOGENE AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Myriad Genetics, Inc
PerkinElmer, Inc
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc
Segment by Type
Oncology Genetic Testing
Cardiology Genetic Testing
Neurology Genetic Testing
Academic and Research
Clinical Diagnostics
Drug Discovery
Monitoring and Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hereditary Genetic Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Hereditary Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hereditary Genetic Testing market research.
Key companies engaged in the Hereditary Genetic Testing industry include Agilent Technologies, Inc, Ambry Genetics, Beijing Genomics Institute (BGI), CENTOGENE AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Inc, Illumina, Inc, Laboratory Corporation of America Holdings and Myriad Genetics, Inc, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Hereditary Genetic Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hereditary Genetic Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hereditary Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agilent Technologies, Inc
Ambry Genetics
Beijing Genomics Institute (BGI)
CENTOGENE AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Myriad Genetics, Inc
PerkinElmer, Inc
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc
Segment by Type
Oncology Genetic Testing
Cardiology Genetic Testing
Neurology Genetic Testing
Segment by Application
Academic and Research
Clinical Diagnostics
Drug Discovery
Monitoring and Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hereditary Genetic Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source